Pharma Mar

Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs. The Company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It also has three clinical-stage programs, including Aplidin, PM1183, and PM184. Pharma Mar develops and provides diagnostics kit for genetic diagnostics and DNA analysis, and produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products.